In general, current studies on NPs and TCM formulas targeting VM formation in ESCC primarily achieve their effects by specifically targeting EphA2, blocking the EMT process, improving the hypoxic tumor microenvironment, and mediating ECM remodeling. This evidence concerns the gene EPHA2 and esophageal squamous cell carcinoma.